AGP Executive Report
Last update: 3 hours agoPharma & Medical Innovation: Chugai’s Hemlibra (emicizumab) team and hemophilia/sleep-disorder researchers won the Lasker-DeBakey Clinical Medical Research Award, underscoring continued momentum in biologics and targeted therapies. Industrial & Energy Deals: Samsung E&A landed a $3.46bn EPC contract for Sabic Agri-Nutrients’ integrated ammonia/urea complex with carbon capture, while Singapore refiner Aster is diversifying crude sourcing beyond the Middle East as Gulf disruptions reshape feedstock flows. Regulation & Public Health: NAFDAC said it lacks direct oversight over unbranded palm oil and traditionally packaged staples sold in open markets, highlighting enforcement gaps; Korea Consumer Agency testing found hazardous chemicals in 60% of claw-machine prizes, with phthalates, lead and cadmium above limits. Chemicals in the Wild: Dubai residents reported a foul, chemical-like smell across multiple areas, with possible links to industrial or sewage sources under scrutiny. Market Watch: Dangote Petroleum Refinery IPO plans are driving investor focus on Nigeria’s oil-and-chemicals complex as equities react to the listing timeline. Safety & Compliance: EPA and state programs push hazardous-waste handling via Detox Your Home events, aiming to keep pesticides and household chemicals out of landfills and waterways.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
